Us Generic Injectables Market Size, Trends and Forecast to 2027
According to the latest report by IMARC Group, titled “US Generic Injectables Market: Industry Trends, Share, Size, Growth, Opportunity and Forecast 2022-2027,” offers a comprehensive analysis of the industry, which comprises insights on the US generic injectables market growth.
The US generic injectables market reached US$ 16.3 Billion in 2021. Looking forward, IMARC Group expects the market to reach US$ 29.6 Billion by 2027, exhibiting a CAGR of 10.21% during 2022-2027. Injectables refer to medication delivery tools that are generally used by healthcare professionals for drug administration into the body. They are widely used as a preferred alternative to oral drugs since injectables are quick in delivering drugs selectively to a specific body part while improving the efficacy of the dosage. Generic injectables are bioequivalent of branded injectables that are manufactured after the expiration of the patent of proprietary injectables. The demand for generic injectables is rising in the US since they are identical in terms of dosage, same active ingredients, side effects, route of administration, strength and quality.
Request a Free PDF Sample of the Report: https://www.imarcgroup.com/us-generic-injectables market/request sample
US Generic Injectables Market Trends:
The market in the US is primarily driven by the augmenting demand for affordable injectables among the masses. This is supported by the rising prevalence of lifestyle disorders due to the sedentary lifestyles led by individuals. Moreover, the increasing funding activities by major players in extensive research and development (R&D) activities for the development of differentiated generic injectables are further creating a positive market outlook. Along with this, several initiatives undertaken by the US government for providing support to key manufacturers and sellers are positively influencing the market. Additionally, the widespread adoption of advanced technologies in the manufacturing process is acting as a major growth-inducing factor across the country. Other factors, including the easy availability of generic injectables via online and offline pharmacies, patent expiration of several blockbuster injectables and the widespread awareness regarding the cost-efficiency of these injectables, are also favorably impacting the market growth.
Key Market Segmentation:
The report has segmented the US generic injectables market on the basis of therapeutic area, containers, distribution channel, end user and region.
Breakup by Therapeutic Area:
Oncology
Anesthesia
Anti-infectives
Parenteral Nutrition
Cardiovascular
Breakup by Containers:
Vials
Ampoules
Premix
Prefilled Syringes
Breakup by Distribution Channel:
Hospitals
Retail Pharmacy
Ask Analyst for Customization and Explore Full Report With TOC & List of Figures: https://www.imarcgroup.com/us-generic-injectables-market
Key Highlights of the Report:
Market Performance (2016-2021)
Market Outlook (2022-2027)
Market Trends
Market Drivers and Success Factors
Impact of COVID-19
Value Chain Analysis
Comprehensive mapping of the competitive landscape
If you need specific information that is not currently within the scope of the report, we will provide it to you as a part of the customization.
About Us
IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.
IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.
Our offerings include comprehensive market intelligence in the form of research reports, production cost reports, feasibility studies, and consulting services. Our team, which includes experienced researchers and analysts from various industries, is dedicated to providing high-quality data and insights to our clientele, ranging from small and medium businesses to Fortune 1000 corporations.
Contact US:
IMARC Group
134 N 4th St Brooklyn, NY 11249, USA
Email: sales@imarcgroup.com
Americas: +1-631-791-1145 | Europe Africa: +44-753-713-2163 | Asia: +91-120-433-0800
Appreciate the creator